Editors:
- Identifies the mechanisms of resistance in immunotoxin-based therapies for cancer
- Explores available measures to overcome and prevent resistance in immunotoxin drugs
- Discusses an array of immune responses in cancer that impact therapeutic strategies
Part of the book series: Resistance to Targeted Anti-Cancer Therapeutics (RTACT, volume 6)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (9 chapters)
-
Front Matter
-
Back Matter
About this book
This book will be a guide to understanding resistance against targeted therapeutic approaches for cancer using immunotoxins. It contains a detailed review of the history and development of targeted therapy. As well, it includes an in-depth description of the molecular and cellular mechanisms involved in cancer resistance and several novel methods to overcome resistance. Each chapter discusses different aspects of resistance and covers all the factors that may contribute to resistance in cancer cells. Finally, this volume highlights the recent findings and advances associated with tackling cancer resistance.
Editors and Affiliations
-
Department of Biotechnology, Indian Institute of Technology Madras, Chennai, India
Rama Shanker Verma
-
Department of Microbiology, Immunology,, University of California of Los Angeles, Los Angeles, USA
Benjamin Bonavida
About the editors
Rama Shanker Verma, Ph.D., is Professor, Department of Biotechnology, the Indian Institute of Technology. Professor Verma specializes in the development of novel immunotoxins for cancer therapies. He has published 76 scientific articles, five book chapters, and several conference abstracts. He is an Elected Fellow, the Association of Microbiologists of India an Elected Fellow, the Society for Applied Biotechnology. He received the award for Excellence in Medical Biotechnology from the Society for Applied Biotechnology.
Bibliographic Information
Book Title: Resistance to Immunotoxins in Cancer Therapy
Editors: Rama Shanker Verma, Benjamin Bonavida
Series Title: Resistance to Targeted Anti-Cancer Therapeutics
DOI: https://doi.org/10.1007/978-3-319-17275-0
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer International Publishing Switzerland 2015
Hardcover ISBN: 978-3-319-17274-3Published: 27 June 2015
Softcover ISBN: 978-3-319-38456-6Published: 17 October 2016
eBook ISBN: 978-3-319-17275-0Published: 11 June 2015
Series ISSN: 2196-5501
Series E-ISSN: 2196-551X
Edition Number: 1
Number of Pages: XVI, 249
Number of Illustrations: 3 b/w illustrations, 19 illustrations in colour
Topics: Cancer Research, Drug Resistance, Pharmacology/Toxicology